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 ABSTRACT 
 
Severe acute respiratory syndrome (SARS) is caused by an enveloped, positive-stranded  
RNA virus, the SARS coronavirus (SARS-CoV).  Coronaviruses along with the 
arteriviruses are placed in the order, Nidovirales.  Even though nidovirus replication is 
restricted to the cytoplasm, the nucleocapsid protein (N) of several coronaviruses and 
arteriviruses, localize to the nucleolus during infection.  Confocal microscopy of N 
protein localization in Vero cells infected with the SARS-CoV or transfected with the 
SARS-CoV N gene failed to show presence of N in the nucleoplasm or nucleolus.  
Recombinant N remained cytoplasmic after the addition of leptomycin B (LMB), a drug 
that inhibits nuclear export.  SARS-CoV N possesses a unique lysine-rich domain, 
located between amino acids 369-389, which possesses several nuclear localization signal 
(NLS) and nucleolar localization signal (NoLS) motifs. A chimeric protein composed of 
the 369-389 peptide substituted for the NLS of equine infectious anemia virus (EIAV) 
Rev protein (ERev) showed no nuclear localization activity.  Three negatively charged 
amino acids, located at positions 372, 377 and 379 in SARS-CoV N were hypothesized to 
play a role in the loss of nuclear targeting.  Substitution of aspartic acid-372 with alanine 
restored nuclear localization to the chimeric protein. A full-length recombinant SARS-N 
protein with the alanine-372 substitution localized to the nucleus. Therefore, the presence 
of an aspartic acid at position 372 is sufficient to retain N in the cytoplasm  The 
mechanistic basis for how aspartic acid-372 interrupts nuclear transport is unknown, but 
may lie in the electrostatic repulsion with negatively charged amino acids located within 
the NLS binding pocket of importin-alpha.   
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Section I 
Introduction and Literature Review 
 
Characteristics of Severe Acute Respiratory Syndrome- Coronavirus Nucleocapsid 
Protein 
 
 
 
 
 
 
 
 
 
 
 2
Introduction 
 
Late in 2002, an outbreak of intense pneumonia infections emerged and spread in the 
GuangDong province of mainland China. An airborne pathogen was determined to be the 
cause of this illness, which was designated Severe Acute Respiratory Syndrome (SARS). 
A global warning was issued by the World Health Organization (WHO). Over 4,300 
SARS cases were reported by late April of 2003, resulting in nearly 250 deaths. Most 
infections occurred after domestic exposure to another SARS patient. The epidemic 
eventually, spread to 30 different countries. By early 2004, over 8000 people were 
infected worldwide; including 800 who died from respiratory failure. Prompt 
implementation of diagnostic and preventative measures brought the spread of SARS 
infections under control by early 2004. The pathogen was determined to be a virus and 
the physical characteristics and genome organization led to the assignment of this virus in 
the Coronavirus family. 
Taxonomy 
 
Coronaviruses and Toroviruses are members of the Coronaviridae family, which along 
with the Roniviridae and Arteriviridae families form the order Nidovirales. 
Coronaviruses are enveloped, single stranded, positive sense RNA viruses that cause 
respiratory and enteric diseases in humans and animals. Coronaviruses were initially 
divided into four antigenic groups. However, differentiation based on the monoclonal 
antibody reactivity, host specificity and genome sequencing replaced the serological 
classification, and eventually classified the family into three groups. Groups 1 and 2 
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contain mammalian viruses, while group 3 primarily consists of avian viruses. Group 2 
viruses are also characterized by the presence of a gene encoding the hemagglutinin 
esterase (HE) protein, which is absent in the other groups (33). Coronaviruses are highly 
host- specific and do not infect other organisms. However, the etiologic agent SARS 
coronavirus (SARS-CoV) (24) is capable of interspecies transmission. The original host 
of this virus was determined to be Chinese Horseshoe bats (Rhinolopus sinicus) and has 
since been isolated from a variety of animals including raccoon dogs, palm civets, 
Chinese ferret badgers and rats. (9, 16, 20). Human coronaviruses cause 30% of colds, 
most of them do not infect the lower respiratory tract like SARS-CoV infections. 
 
SARS-CoV was initially believed to be a representative of a new fourth group in the 
Coronavirus family, due to lack of obvious similarities with any other established group. 
However, closer analysis of the replicase gene of the virus revealed that the virus is most 
closely related to the group 2 of the coronavirus family (35). Thus its placement in a new 
group, 2b, has been proposed. 
 
Virus structure and genome organization 
 
The viruses are named coronaviruses due to the appearance of the viral particles under a 
microscope. The presence of the spike protein that is present on the surface of the viral 
particles gives it a crown-like appearance (Fig 1.1). This protein is responsible for viral 
attachment and entry. The virus also has a number of other structural proteins, including 
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Small envelope 
Glycoprotein 
Spike protein 
 
 
 
 
 
Hemagglutinin 
esterase 
protein 
 
Nucleocapsid  
Protein 
 
RNA 
 
 
 Membrane 
glycoprotein 
the Membrane glycoprotein (M), the Envelope protein (E)  and the Nucleocapsid (N) 
protein as well as the single stranded RNA. 
Fig 1.1 Structure of SARS coronavirus  
 
SARS genome is approximately 29.7 kb and contains 40% GC residues. The genomic 
organization of the coding sequences of SARS-CoV is typical of other coronaviruses. 
The gene order is [5΄-replicase (rep), spike(S)-envelope (E)-membrane (M) and 
nucleocapsid (N)-3΄]. The rep gene comprises a large portion of the genome and codes 
for two polyproteins which undergo co-translational proteolytic processing. The genome 
also encodes multiple non-structural proteins (Fig 1.2; 33). Coronaviruses (CoV) 
replicate within the cytoplasm of the host cell. The positive-sense, single stranded 
genome contains a 5΄ cap structure and a polyadenylated 3΄ tail. The structural proteins 
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are translated from a 3΄-coterminal nested set of subgenomic mRNAs. Each subgenomic 
RNA contains a common leader sequence identical to the 5΄ leader sequence of the 
genome. The subgenomic mRNAs are formed by a discontinuous transcription 
mechanism during negative strand synthesis (Fig 1.2). Due to this discontinuous 
transcription mechanism, there is a high degree of RNA recombination. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1.2 Genome organization of SARS genome. 
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Nucleocapsid (N protein): 
 
The nucleocapsid protein is a major structural protein of the coronavirus. The SARS-CoV 
is 422 amino acids in length and 47KDa in mass. SARS-CoV n protein shares only 20-
30% homology with N proteins from other known coronaviruses. PSORT sequence 
analysis reveals the presence of multiple nuclear localization signal sequences (NLSs) as 
well as presence of a unique leucine rich region and a serine-arginine rich region. SARS-
N does not contain any cysteine residues and recombinant protein expression results in 
protein that is labile and easily degradable (6, 40, 41, 44) 
 
Sequence homology of SARS-CoV N protein with other Coronavirus N proteins 
 
Figure 1.3 displays the sequence alignment between SARS N with N proteins of two 
members of group 2 Bovine Coronavirus (BCV) and Murine hepatitis virus (MHV- A59). 
Surprisingly, even though SARS-N was sequentially most similar to this group, the 
percentage identity was is found to be very low (31% with MHV and 29% with BCV). 
When a sequence comparison was performed with members of the other groups of the 
family, the percentage identity was further decreased (21% with TGEV and PDEV and 
26% with IBV; data not shown).  
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 BCV-N          MSFTPGKQSSS-RASSGNRSGNGILK---WADQSDQSRNVQTRGRR-AQPKQTATSQQPS 
 MHV-N          MSFVPGQENAGGRSSSVNRAGNGILKKTTWADQTERGPNNQNRGRR-NQPKQTATTQ-PN 
 SARS-N         ------------MSDNGPQSNQRSAPRITFGGPTDSTDNNQNGGRNGARPKQRRPQGLPN 
                            :::: :::::::::  :::::::   *:*::**: ::***:::   *: 
 
 BCV-N          GGNVVPYYSWFSGITQFQKGKEFEFAEGQGVPIAPGVPATEAKGYWYRHNRRSFKTADGN 
 MHV-N          SGSVVPHYSWFSGITQFQKGKEFQFAEGQGVPIANGIPASEQKGYWYRHNRRSFKTPDGQ 
 SARS-N         NT-----ASWFTALTQHGK-EELRFPRGQGVPINTNSGPDDQIGYYRRATRR-VRGGDGK 
                .: ::: :***:::**::*::*: *:*:*****: : :: :::**::*::**:::* **  
 
 BCV-N          QRQLLPRWYFYYLGTGPHAKDQYGTDIDGVFWVASNQADVNTPADILDRDPSSDEAIPTR 
 MHV-N          QKQLLPRWYFYYLGTGPHAGASYGDSIEGVFWVANSQADTNTRSDIVERDPSSHEAIPTR 
 SARS-N         MKELSPRWYFYYLGTGPEASLPYGANKEGIVWVATEGALNTPKDHIGTRNPNNNAATVLQ 
                : :*:************:*   **   :*::***  :*: ::  :*  *:::: :**::: 
 
 BCV-N          FPPGTVLPQGYYIEGS-GRSAPNSRSTSRASSRASSAGSRSRADSGNRTPTSGVTPDMAD 
 MHV-N          FAPGTVLPQGFYVEGS-GRSAPASRSGSRSQSRGP--NNRARSSSNQRQPASTVKPDMAE 
 SARS-N         LPQGTTLPKGFYAEGSRGGSQASSRSSSRSRGNSR---NSTPGSSRGNSPARMASGGGET 
                :::**:**:*:* *** *:*:: *** **: ::      : : :*  : *:: : ::::.    
 
 BCV-N          QIASLVLAKLGKDATKP-----QQVTKQTAKEIRQKILNKPRQKRSPNKQCTVQQCFGKR 
 MHV-N          EIAALVLAKLGKDAGQP-----KQVTKQSAKEVRQKILNKPRQKRTPNKQCPVQQCFGKR 
 SARS-N         ALALLLLDRLNQLESKVSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKQYNVTQAFGRR 
                 :* *:*::*::::  :     :*:::: :*  ::::::******:::*** *:*:**** 
 
 BCV-N          GPNQ---NFGGGEMLKLGTSDPQFPILAELAPTAGAFFFGSRLELAKVQNLSGNLDEPQK 
 MHV-N          GPNQ---NFGGSEMLKLGTSDPQFPILAELAPTVGAFFFGSKLELVKKN--SGGADEPTK 
 SARS-N         GPEQTQGNFGDQDLIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTP----------- 
                **:*   ***: :::::**:::::*::*: **:::***::*::::::    ::  ::: :                
 
 BCV-N          DVYELRYNGAIRFDSTLSGFETIMKVLNENLNAYQQQDGMMNMSPKPQRQ--RGQKNGQG 
 MHV-N          DVYELQYSGAVRFDSTLPGFETIMKVLNENLNAYQKDGGADVVSPKPQRKGRRQAQEKKD 
 SARS-N         SGTWLTYHGAIKLDDKDPQFKDNVILLNKHIDAYKTFPPTEPKKDK-KKKTDEAQPLPQR 
                ::::* * **:::*:: ::*::::::**::::**:::::::: ::*::::  : :       
 
 BCV-N          ENDNISVAAPKSRVQQNKSRELTAEDISLLKKMDEPYTEDTSEI----- 
 MHV-N          EVDNVSVAKPKSSVQRNVSRELTPEDRSLLAQILDDGVVPDGLEDDSNV 
 SARS-N         QKKQPTVTLLPAADMDDFSRQLQNSMSGASADSTQA------------- 
                : :: :*: :::::: : **:*: :: ::::                      
 
 
 
Fig 1.3 Sequence homology between SARS-N and group II coronavirus N proteins. 
Sequences from the nucleocapsid proteins from the coronaviruses of group II and SARS-
CoV mentioned above were obtained from Genbank and multiple alignment of these 
sequences was done using CLUSTAL W analysis. The common amino acids are denoted 
by (*) and amino acid that are conserved in 2 out of the three sequences is denoted by (:).  
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  Structure and functions of SARS-CoV N protein 
 
Multiple roles have been attributed to the N protein of coronaviruses throughout the virus 
life cycle. Primarily, the association of N protein with genomic RNA forms the ribo-
nucleocapsid structure and this in turn associates with the M protein to form the viral core. 
N protein plays a role in viral pathogenesis and anti-N monoclonal antibodies have been 
shown to protect mice from lethal infection as well as inhibit viral transcription. N 
protein is believed to play a role in transcription of viral genome by its association with 
the viral genomic and sub genomic RNAs (1, 31, 34). This interaction is mediated by the 
binding signals in the leader RNA sequences and is specific to the viral RNA.  
 
The Coronavirus N protein can be divided into three putative regions, the N-terminal 
domain, the RNA-binding domain and a C-terminal domain. The N and C terminal are 
believed to play a role in molecular interactions with other proteins. The C-terminal end 
plays an important role in dimerization of the protein. However, the mid portion of 
SARS-N interacts with the M protein and hnRNP-A1 protein and the N-terminal domain 
(between amino acids 45-181) of the protein is shown to interact with viral RNA (7, 10, 
13, 15, 28 ). Therefore, a recent study by Chang et al. (2) analyzed the modular 
organization of SARS-CoV nucleocapsid protein. Using NMR (nuclear magnetic 
resonance) techniques their observations proved that SARS-CoV N protein consists of 
two non-interacting, independent structural domains. The first domain is the N-terminal 
RNA interacting domain whereas the residues of the second domain at position 248-365 
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at the C-terminal are termed the dimerization domain. These domains are surrounded by 
flexible linkers and these linkers act as potential interaction sites with other proteins.  
 
The most important biochemical property of the N protein is its capacity to self-associate. 
N proteins of many coronaviruses can form dimers and oligomers. Dimer formation is 
observed both for recombinant proteins as well as during viral infection (5, 29). As with 
other coronaviruses, dimerization and oligomerization of the SARS-N protein has been 
extensively studied. Surjit et al. (38) investigated the self association of SARS 
nucleocapsid protein through a yeast two hybrid assay analysis. They mapped the self 
association site to the C-terminal 209 amino acids. In a similar study, Yu et al. (45) 
showed that recombinant N protein is capable of forming dimers and higher weight 
oligomers at high concentrations. The dimerization domain was determined to be at the 
C-terminal 138 residues (45). Another study conducted with He et al determined that the 
serine-arginine rich motif (SSRSSSRSRGNSR) is crucial for N-N oligomers formation 
and deletion of this motif leads to loss of N-N interaction. They believe that this self 
association may play an important role in ribonucleoprotein formation and subsequently 
in the viral assembly process (10).  
 
Interaction of SARS- N protein with viral RNA 
 
The coronavirus N-protein interacts with the viral RNA genome to form a helical 
nucleocapsid structure. Specific interactions between the N protein and coronavirus 
leader RNA have been defined. Anti-N antibodies precipitate full length as well as 
 10
subgenomic RNAs from infected cells (1) This interaction plays a role in a number of 
viral processes including viral RNA dependent RNA transcription, genome replication 
and translation (31).  Synthesis of coronavirus mRNA takes place via a discontinuous 
transcription process that results in fusion of a leader RNA sequence to the subgenomic 
RNA body sequence. Although several models have been proposed for this procedure, 
the exact mechanism of action for this process is still unknown. Nucleic acid binding 
activity of Coronavirus N has been studied for MHV, BCV and IBV. This interaction was 
found to be specific to viral RNA and was not affected by the addition of non specific 
competitor RNA (36). Binding of the N protein to the viral RNAs occurs via the leader 
sequence since this is the common component of these RNAs. Studies with IBV N-
protein have determined the presence of two RNA binding regions of the N protein; one 
in the C-terminal and the other at the N-terminal region of the N-protein that interact with 
the genomic RNA. However, RNA binding domain of MHV-N protein was determined to 
be within 136-397 residues (25). Nelson and Stohlman (30) further determined the 
binding domain to 169-308 amino acid residues of the MHV N-protein. Using chimeric 
BCV and MHV N-proteins, the RNA binding domain was determined to be between 
residues 163-380 (32). Using bacterial expression of MHV-N protein and RNA probes, 
the region of interaction for RNA and N protein binding was finally determined to be in a 
central 50 amino acid residues (177-231) of this fragment. This fragment is found to be 
rich in serine and arginine residues (31). This motif is conserved in all coronavirus N 
proteins, including SARS-CoV N protein. Using NMR, Huang et al. (13) recently 
determined the structure of the N-terminal binding domain of the SARS-N protein, 
specifically residues 45-181. This N-terminal domain had very little structural similarity 
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to any other coronavirus N protein. However, upon visualizing the three dimensional 
structure, it was determined that this domain had remarkable similarities to other 
ribonucleoprotein RNA binding proteins. These similarities included presence of 
positively charged lysine and arginine residues on the surface. Addition of untranslated 
viral 3΄ RNAs confirmed the binding capacity of this domain. The authors also found 
various small molecules capable of binding to this region by NMR based screening (13). 
The interaction of the N protein is believed to take place due to the chemical exchange 
between the lysine and arginine residues and the phosphate backbone of the RNA 
molecules. Therefore, despite low homology with other coronavirus N-proteins, the RNA 
binding region of SARS-CoV N-protein consists of structural features consistent with 
RNA binding proteins (14). 
 
Interaction of SARS-N with cellular proteins 
 
The association of hnRNP-A1 with N-protein has been established in MHV nucleocapsid 
protein studies. Using mammalian expression systems, hnRNP-A1 and viral N-protein 
were expressed and the in vitro as well as in vivo association of these proteins was 
determined. It was determined, using yeast two hybrid assays that these proteins 
physically associated in a specific manner and independent of their association with the 
viral RNA. Using a series of deletion mutants, the binding site of hnRNP-A1 with MHV 
N-protein was determined in two regions of the protein using yeast two hybrid assays. 
The N-protein was associated with RNP-A1 via its N-terminal region (1-292) and at 
another site at the carboxyl terminal end (391-455). This association is believed to play 
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an important role in regulation of MHV RNA synthesis (41). Recently, the association 
between SARS-N protein and hnRNP-A1 has been studied using biophysical and 
biochemical assays (22).  It was determined that SARS N-protein has a high binding 
affinity for hnRNP-A1. The association was mapped to the 161-210 amino acid fragment 
of SARS-N and to the 203-320 glycine rich region of hnRNP-A1. The authors postulated 
that this association plays an important role in SARS-CoV RNA synthesis.  
 
Another cellular protein that is associated with SARS-N is human Cyclophilin A 
(hCypA). Cyclophilins were initially discovered because of their affinity to the 
immunosuppressive drug Cyclosporine A. More recently, it has been determined that 
cyclophilins play an important role in HIV infection via their association with the HIV-1  
Gag polyprotein (37). Sequence comparison of SARS-N protein with the HIV capsid 
domain of the HIV-Gag protein shows moderate similarity (36.7%). The binding of 
Cyclophilin A with SARS N protein was confirmed using surface plasmon resonance 
(SPR) biosensor technology (22, 23). SARS-N protein associates with Cyclophilin A via 
the Trp-302-Pro310 loop, of which the Trp302 residue was major requirement 
recognition. The significance of this association is not established. However, HIV studies 
have reflected on decrease in viral entry and infection upon addition of CypA inhibitor 
CsA. Fig 1.3 describes a schematic representation of the various domains of SARS-N. 
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Fig 1.4 Diagrammatic representation of SARS- N domains.  
 
Posttranslational modifications of SARS-N protein: 
 
Several coronavirus N proteins have shown to be phosphorylated including IBV, MHV 
and TGEV N proteins even though the exact sites of phosphorylation of these have not 
been identified (3). Although the exact role of N protein phosphorylation is unknown, 
phosphorylation is postulated to play a role in determining its binding affinity to viral 
RNA. Using surface plasma resonance, it was demonstrated that phosphorylation of N 
protein decreased its binding affinity for random RNA. Phosphorylation may thus lead to 
the preferential binding of viral RNA over cellular RNA (3).  
 
4221
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             RNA binding domain 
         45                                 181 
                                    Hn RNP-A1                                                            hCypA 
                    161                                               210                          302                          310 
          Y-62  
Sumoylated lysine 
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Dephosphorylation of coronavirus N protein takes place with the help of cellular 
phosphoprotein phosphatases and dephosphorylation facilitates viral infection by 
promoting dissociation of the N protein from the viral ribonucleoprotein complex. (26) 
 
Serine phosphorylation of SARS-CoV N protein was initially reported by Surjit et al. (38). 
They determined that the phosphorylated SARS-N predominantly localized in the 
cytoplasm of the cells and associated with the membrane. They also demonstrated the 
phosphorylation dependent binding of N protein with 14-3-3 and postulate that this 
interaction facilitates the cytoplasmic localization. The inhibition of 14-3-3 expression by 
RNA interference leads to SARS-N accumulation in the nucleus of the cell (39). 
 
Recently, Li et al. (18) reported sumoylation of the SARS-N protein. Because the N 
protein does not contain any cysteine residues, the dimerization and oligomerization of 
SARS-N must be due to other interactions. Sumoylation is described as the covalent 
attachment of a small ubiquitin like modifier (SUMO) to the protein. The sumoylation 
site of SARS-N was mapped to the lysine residue at position 62. Mutation of the K62 
residue (K62A) using site directed mutagenesis demonstrated loss in SARS-N 
oligomerization and this led to the conclusion that sumoylation drastically promotes 
homo-oligomerization of the SARS-N protein. (18). 
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Intracellular localization properties of coronavirus N proteins 
 
One of the foremost ways to determine the functional significance of a protein is to 
determine its localization properties inside the cells. The N protein is primarily found in 
the cytoplasm, which is consistent with role as a structural protein. Studies of the IBV N 
protein showed significant accumulation of N protein in the nucleus. Confocal 
microscopic analysis determined that this sub-nuclear structure was the nucleolus of the 
cell (12). Further studies determined that nucleolar localization was also a common 
feature among other members of the coronavirus family. Nuclear localization was 
observed in TGEV, a member of group I and MHV, a member of group II of the family. 
These proteins were found to co-localize with nucleolin, a nucleolar protein and was 
believed to abrogate cell division (43). Co-localization with fibrillarin was also observed 
(4).  
 
 Translocation of nuclear proteins from the cytoplasm, across the nuclear pore complex 
(NPC), and into the nucleus is initiated by the binding of a nuclear localization signal 
(NLS) on the cargo protein to importin-α. The cargo/importin-α complex , binds to a 
second shuttle protein, importin-β, which is then targeted to the NPC. In the presence of 
additional accessory proteins, including Ran-GDP, the cargo/importin complex is 
transported across the NPC and released into the nucleoplasm (8). Classical NLS 
sequences incorporate regions enriched in basic amino acids and generally conform to 
one of three types (11, 27).  The pat4 NLS consists of a continuous stretch of four basic 
amino acids (lysine or arginine) or three basic amino acids associated with histidine or 
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proline. The pat7 NLS starts with a proline and is followed within three residues by a 
segment containing three basic residues out of four. The third type of NLS, known as a 
bipartite motif, consists of two basic amino acids, a 10 amino acid spacer, and a five 
amino acid segment containing at least three basic residues.  Nucleolar localization 
results due to presence of the nucleolar localization signal (NoLS) in combination with 
classic NLSs and nuclear targeting signals (NTS). Nucleolar localization is usually 
preceded by nuclear translocation following targeting to the nucleolus.  
 
The localization domains of SARS-CoV N protein were determined by PSORT computer 
program. For the purpose of comparison, we also analyzed N proteins of other 
coronaviruses. As described in Table 1, the available sequence information from 
GenBank indicates that all coronavirus N proteins possess at least one localization 
domain. Furthermore, these domains are generally confined to one of three regions within 
the protein; residues 14 to 60, 200-280, and 326-400. Within this group, SARS-CoV is 
the only N protein with NLS sequences in all three regions. The SARS-CoV N protein 
has two pat4 and four pat7 localization domains. Furthermore, besides FECV, SARS-
CoV was the only known coronavirus to possess a bipartite signal sequence.  
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Table 1: Predicted NLSs by PSORT analysis 
    Localization signals predicted by PSORT  
Virus 
Strain 
Accession number 
GenBank 
No. 
Pat 4 Pat 7 
 
    Bipartite 
 
Coronavirus Gp I    
Transmissible 
gastroenteritis virus 
(TGEV) 
YOO542 
 
 
340-RKRK NONE NONE 
HCV-Human 
Coronavirus (HCV-
229E) 
NP073556 
 
NONE 45-PINKKDK 
198-PQEKDKK 
247-PRWKRQP 
 
 
NONE 
Feline coronavirus 
(FECV) 
CAA74230 NONE 14-PSKRRGR 326-KRPSEVAKD 
       QRQRKSRS 
Coronavirus Gp II     
Human coronavirus 
(HCV-OC43) 
 
NC 005147 
 
NONE 270-PRQKRSP NONE 
Murine Hepatitis 
virus (MHV-JHM) 
 
M25875 
 
NONE 271-PRQKRTP 
391-PKPQRKR 
393-PRKRGT 
 
NONE 
Bovine coronavirus 
(BCoV-ENT) 
NC_003045 
 
NONE 
 
270-PRQKRSP NONE 
Porcine 
Hemagglutinating 
encephalomyelitis 
virus (PHEV) 
AAL80036 
 
NONE 270-PRQKRSP NONE 
Severe acute 
respiratory syndrome 
coronavirus 
(SARS-CoV- 
Urbani) 
AY278741 257-KKPR 
373-KKKR 
38-PKQRRPQ 
259-PRQKRTA 
369-PKKDKKK 
384-PQRQKKQ 
 
373-KKKKTDEAQ 
       PLPQRQKK 
374-KKKTDEAQP 
       LPQRQKKQ 
 
Coronavirus gp III     
IBV-Avian 
infectious Bronchitis 
virus-Beaudette 
NC_001451 
 
359-RPKK 360-PKKEKKL NONE 
 
Turkey coronavirus 
(TCV) 
AAF23873 
 
359-RPKK 
364-KKPK 
365-KPKK 
360-PKKEKKP  
NONE 
Family Arteriviridae 
Porcine reproductive 
and respiratory 
syndrome virus 
(PRRSV-PA8) 
AF176348 
 
10-KRKK 41-PGKKNKK NONE 
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Immunogenic properties of SARS-N protein 
 
Coronavirus N protein is highly immunogenic and humoral response for SARS-N was 
observed for over 90% of patients infected with SARS-CoV (17, 20). Additionally, 
studies involving a plasmid encoding full-length SARS-N have been utilized to study its 
effect as a DNA vaccine (46). This vaccination in BALB/c mice led to strong antibody 
response involving increased cytokine secretion specifically that of IFN-γ and IL-2. More 
importantly, these vaccinated mice exhibited delayed hypersensitivity reactions and 
cytotoxic T cell response. A different study conducted by Liao et al (21) analyzed the 
interaction of SARS-CoV N protein and NF-κB. The transcription factor NF-κB activates 
several genes involved both in inflammation as well as cell mediated immune response 
including TNF- α, IL-2, IL-6 and IL-8. Liao et al. observed that full length N protein 
significantly increased NF-κB activity in a dose dependent manner. The humoral and cell 
mediated immune reactions in response to SARS-CoV N protein indicate that this protein 
may be involved in the viral pathogenesis of  SARS. This protein can be used for 
development of vaccination and therapeutics for the treatment of SARS. 
 
In conclusion, SARS-CoV N protein does not show significant similarities to any known 
coronavirus N proteins. Presence of unique serine-arginine rich region, multiple NLSs as 
well as unique cellular localization pattern make this protein an interesting study subject. 
Research involving molecular mechanisms of SARS-CoV N protein holds great promise 
for designing therapeutics as well as diagnostic tools for the virus infection. 
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Section 2 
 
 
 
Intracellular localization of the SARS coronavirus nucleocapsid protein: 
absence of nucleolar accumulation during infection and after expression 
as a recombinant protein in Vero cells. 
 
 27
ABSTRACT 
 
The nucleocapsid (N) protein of several members within the order Nidovirales localizes 
to the nucleolus during infection and after transfection of cells with N genes. However, 
confocal microscopy of N protein localization of Vero cells infected with the severe acute 
respiratory syndrome coronavirus (SARS-CoV) or transfected with the SARS-CoV N 
gene failed to show the presence of N in the nucleoplasm or nucleolus. Amino acids 369-
389, which contain putative nuclear localization signal (NLS) and nucleolar localization 
signal (NoLS) motifs, failed to restore nuclear localization to an NLS-minus mutant Rev 
protein. These data indicate that nuclear localization is not a conserved property within 
the Nidovirales.  
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Introduction 
 
Severe acute respiratory syndrome (SARS) is caused by an enveloped, positive-stranded  
RNA virus, the SARS coronavirus (SARS-CoV). Along with the arteriviruses, 
toroviruses and roniviruses , the coronaviruses are placed in a single order, Nidovirales 
(Cavanagh, 1997). Even though nidovirus replication is restricted to the cytoplasm, the 
nucleocapsid protein (N) of two arteriviruses, porcine reproductive and respiratory 
syndrome virus (PRRSV) and equine arteritis virus (EAV), have been reported to localize 
to the nucleolus during infection (19,20,23,25). An identical cytoplasmic-nucleolar 
distribution pattern has also been reported for the N proteins of several coronaviruses, 
including representative members of group I (transmissible gastroenteritis virus; TGEV), 
group II (mouse hepatitis virus; MHV), and group III (infectious bronchitis virus; IBV) 
viruses. These arterivirus and coronavirus N proteins, when expressed alone or fused to 
the red-shifted  enhanced green fluorescent protein (EGFP), also localize to the nucleolus, 
demonstrating that translocation across the nuclear pore complex (NPC) and 
accumulation in the nucleolus are independent of other viral proteins (11, 20, 23). Once 
inside the nucleolus, the PRRSV and IBV N proteins co-localize with major nucleolar 
proteins, including nucleolin and fibrillarin (4, 25). The capacity of N to modulate 
nucleolar function may represent a viral strategy that diverts biosynthetic resources from 
the dividing nucleus to the cytoplasm, the site of virus replication (10, 11, 21, 25 ). There 
also appears to be a mechanism for the export of N from the nucleolus and back to the 
cytoplasm. The N proteins of PRRSV and EAV accumulate in the nucleus in response to 
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the treatment of cells with lemptomycin B (LMB; 21, 23), an inhibitor of the export 
shuttle protein, CRM1. ( 7 ). 
 
The classical scheme for the translocation of a protein from the cytoplasm through the 
nuclear pore complex and into the nucleoplasm is initiated through the interaction 
between a nuclear localization signal (NLS) on the cargo protein with the NLS-binding 
site on importin-a (reviewed in 2,8). Classical NLS sequences are enriched in basic 
amino acids, such as lysines and arginines, and generally conform to one of three types, 
known as monopartite (pat4and pat7) and bipartite motifs (9,17) The pat4 NLS is defined 
as a continuous stretch of four basic amino acids (lysine or arginine) or three basic amino 
acids associated with histidine or proline. The pat7 NLS starts with proline followed 
within three residues by a segment containing three basic residues out of four. The 
bipartite motif, consists of two basic amino acids, a ten amino acid spacer, and a five 
amino acid segment containing at least three basic residues (reviewed in 9 and 17). The 
nuclear transport of the PRRSV N protein is dependent on a single pat7 NLS, 41-
PGKKNKK, which overlaps the RNA binding domain (20, 21, 22, 25). Site-directed 
scanning mutagenesis identified the requirement of the four lysine residues, 43-KK and 
46-KK, for the transport of N into the nucleus (21). A second NLS, 10-KRKK, is located 
upstream and functions as a cryptic NLS, which becomes accessible following a 
conformational change in the N protein (20, 21). The nucleolus is not a membrane-bound 
organelle; therefore, the localization of a protein to the nucleolus occurs by diffusion 
through the nucleoplasm and accumulation in the nucleolus via a trans-acting nucleolar 
targeting signal (NoTS). Viral proteins frequently combine an NLS and NoTS into a 
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single localization signal sequence, often referred to as a compact nucleolar localization 
signal (NoLS) sequence (14, 15). Compact NoLS sequences are typically no longer than 
30 amino acids and possess at least nine basic amino acids, including at least one NLS 
motif (14).  
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Results and Discussion 
 
When analyzed for the presence of NLS-like signal sequences using the computer 
program PSORT (17), the 422 amino acid SARS-CoV N protein is shown to possess as 
many as eight NLS motifs, which are distributed between amino acids 38-44, 257-265 
and 369-389 (Fig. 2.1). Embedded within the 369-389 domain are five NLS motifs, 
including a lysine enriched peptide sequence, 369-PKKDKKK-375, which possesses 
similarities to the pat7 NLS in PRRSV N (20) and the well characterized NLS, 126-
PKKKRLV, found in the SV40 large T antigen (13). In addition, the 369-375 region 
resembles the putative NLS sequence, 360-PKKEKKL, reported for the IBV N protein 
(24). The 369-389 region shares similarities with NoLS domains found in nucleolar 
proteins of other viral proteins, including HIV Rev, HIV Tat, HTLV Rex, and the capsid 
protein of Semliki Forest virus ( 6, 14, 15, 20). 
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Fig. 2.1. NLS motifs in SARS-CoV N protein. Peptide sequence analysis of the SARS-
CoV N protein Urbani isolate (GenBank accession no. AY278741) using the Web-based 
program, PSORT (17). The rules for defining pat4, pat7 and bipartite motifs are discussed 
in the introductory comments of the text.  
38-PKQRRPQ (pat7)  
 
257-KKPRQKRTAKKPR (pat4) 
PRQKRTA (pat7)  
 
369-PKKDKKKKTDEAQPLPQRQKKQKKKK (pat4) 
PKKDKKKK (pat7) 
PQRQKKQ (pat7) 
KKKKTDEAQPLPQRQKK (bipartite) 
KKKTDEAQPLPQRQKKQ (bipartite)  
 
 
The localization of SARS-CoV N during infection was studied using confocal 
microscopy of infected cells stained with SA 46-4, a SARS-CoV N protein-specific mAb 
prepared in our laboratory against recombinant N prepared from the SARS-CoV Urbani 
isolate. Nuclei were identified using the nucleic acid stain, TO-PRO-3 (Molecular Probes; 
Maziere et al., 1996). Vero cells (ATCC), grown on coverslips, were mock-infected or 
infected with SARS-CoV (Urbani isolate) at a multiplicity of infection of 0.1. Coverslips 
were removed at 6, 12 and 24 h after infection, washed with PBS, fixed for 10 minutes 
with 2% paraformaldehyde in PBS, and then stained with SA 46-4 followed by anti-
mouse IgG antibody conjugated to AlexaFluor 594 (Molecular  Probes). All antibodies 
were diluted 1:500 in blocking buffer (PBS containing 3% normal goat sera and 0.2% 
saponin) and incubations performed for 1 h at room temperature followed by extensive 
washing in PBS. Cells were counterstained with TO-PRO-3, diluted in blocking buffer, 
then viewed on a Zeiss LSM 510 confocal microscope. In each experiment at least 50 
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infected cells in 10 distinct fields were analyzed. Representative results at 24 h after 
infection are presented in Fig. 2.2. A group of infected cells, presented in Fig. 2.2A, 
shows no evidence for anti-N staining in the nucleus and nucleolus. A higher 
magnification of a representative cell is presented in Fig. 2.2 B, C, D. We found no co-
localization between SA 46-4 staining and the nuclear stain, TO-PRO-3. The same results 
were obtained from cells fixed and stained with SA 46-4 and TOPRO-3 at 6 and 12 h 
after infection (data not shown). Wurm et al. (24) reported the nucleolar localization of 
coronavirus N proteins in Vero cells transfected with N genes from TGEV, MHV and 
IBV, and stained with anti-N antibodies. IBV N tagged with EGFP also localized to the 
nucleolus of Vero cells (11).  
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Fig.2.2. Distribution of N in SARS-CoV-infected cells. (A) Confocal microscopy of a 
cluster of infected cells at 24 h after infection. Viral antigen was detected using 
AlexaFluor 594-labeled SA 46-4 anti-N mAb (red). Cells were counterstained with the 
nuclear stain, TO-PRO-3 (blue). (B, C and D) are images of a single representative 
infected cell at 24 h after infection. (B) AlexaFluor 594-labeled SA 46-4. (C) TO-PRO-3 
staining. (D) Merged image combining SA 46-4 and TO290 PRO-3 staining. An 0.8 um 
slice through the nucleus is shown in each image. Images were obtained with a 63x oil 
objective and panels B,C and D are magnified 2x 
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We performed similar studies of the SARS-CoV N gene expressed in Vero cells. A 
cDNA containing the N gene of SARS-CoV Urbani isolate was cloned into pIRES-EGFP, 
pEGFP-N1 and pEGFP-C2 eukaryotic expression vectors (Clontech). The pIRES-EGFP 
vector construct, pSARS-N-IRES-EGFP, through the incorporation of an internal 
ribosome entry site (IRES) separating the SARS-CoV N and EGFP genes, expresses 
EGFP and N as separate proteins. The other vectors express N as an EGFP fusion protein 
with the N protein fused in frame to the amino (SARS-N-EGFP) or carboxyl (EGFP-
SARS-N) end of EGFP. The transfection of plasmid DNA into Vero cells was performed 
using Lipofectamine (Invitrogen) according to the manufacturers directions. A 
representative cell at 24 hr after transfection pSARS-N-EGFP is shown in Fig. 2.3 panels 
A, B and C. Confocal microscopy showed that SARS-N-EGFP fluorescence was 
restricted to the cytoplasm with no visual evidence for N in the nucleolus. Similar results 
were obtained for Vero cells transfected with pSARS-N-IRES-EGFP and stained with the 
anti-N mAb, SA 46-4 (data not shown). Hiscox et al. (11) reported only a small 
percentage of cells with IBV N protein in the nucleus/nucleolus. In cells transfected with 
pSARS-N-EGFP or pEGFP-SARS-N, we noticed that a small number of cells contained 
at least some EGFP fluorescence in the nucleoplasm, but not in the nucleoli. A single cell 
exhibiting EGFP fluorescence in the nucleus and stained with SA 45-4 is shown in Fig. 
2.3D. The intensity of red (SA 46-4) and green (EGFP) fluorescence taken along a single 
axis through the cytoplasm and nucleus is presented in the profile below the 
photomicrograph. The fluorescence intensity profiles show that red fluorescence is 
primarily restricted to the cytoplasm (see Fig. 2.3D); whereas, EGFP fluorescence can be 
found in both nuclear and cytoplasmic compartments, but is restricted from the nucleoli.  
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Fig 2.3 Localization of SARS-CoV N-EGFP in Vero cells. (A, B, C) Confocal 
microscopic images of a single cell at 24 hr after transfection with pSARS-N-EGFP. (A) 
EGFP fluorescence, (B) TO-PRO-3 fluorescence, (C) Merged image. (D) Image of a 
single cell transfected with pSARS-N-EGFP and exhibiting EGFP fluorescence in the 
nucleus. The cell was counterstained with AlexaFluor 594-labeled SA46-4 anti-N mAb 
(red). Below the image is a profile showing the intensity of EGFP (green line) and 
AlexaFluor 594 (red line) fluorescence along the axis shown by the dotted arrow.  
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The possibility that EGFP fluorescence in the nucleus was the result of free EGFP was 
confirmed by performing a Western blot of Vero cells transfected with pSARS-N-EGFP 
or pEGFP-SARS-N constructs. Proteins in cell lysates were separated by SDS PAGE, 
transferred to a nylon membrane and probed with anti-GFP antibody. The blot showed 
the presence of full-length N-EGFP and EGFP-N fusion proteins, as well as smaller-sized 
products, including immunoreactive proteins which migrated the same as free EGFP 
(data not shown). Therefore, the presence of EGFP in the nucleus of some transfected 
cells is the likely result of the proteolytic cleavage of the SARS-N EGFP fusion protein 
and release of smaller sized EGFP-labeled fragments. Collectively, the results from 
infected and transfected cells indicate that SARS-CoV N does not appear to target the 
nucleolus or nucleus. One possible explanation for the absence of detectable amounts of 
N in the nucleus is that N enters the nucleus, but is rapidly exported. Therefore, under 
steady state conditions only a small quantity of N would be visible in the nucleus at any 
one time. In order to test this possibility, we treated pSARS-N-EGFP transfected cells 
with the nuclear export blocker, LMB, an antibiotic which inhibits CRM1, the major 
export shuttle protein (7, 18). LMB, at concentrations up to 50nM, was added to Vero 
cells between 4 and 18 h after transfection. After addition of LMB, the live cells were 
then followed under a fluorescence microscope for an additional 24 h. Cells transfected 
with a recombinant equine infectious anemia virus Rev (ERev) cDNA fused to 
EGFP(pEGFP-ERev) were included as a positive control. The continuous shuttling of 
ERev back and forth between the cytoplasm and the nucleus is dependent on single NLS 
and nuclear export signal (NES) domains (16, 18). The majority of Vero cells transfected 
with pERev-EGFP showed the presence of ERev-EGFP fusion protein in the cytoplasm 
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(Fig. 2.4A). In the presence of 10 nm LMB, the distribution pattern shifted towards the 
accumulation of ERev-EGFP in the nucleus (Fig. 2.4B). Accumulation of ERev-EGFP in 
the nucleus appeared as early as 6 h after the addition of LMB. Fig. 2.4C and D show 
representative results for cells transfected with pSARS-N EGFP and treated with LMB. 
The addition of LMB did not alter the cytoplasmic distribution of SARS-N-EGFP. The 
same result was obtained for cells transfected with pSARS-N-IRES-EGFP and stained 
with SA 46-4 (data not shown). LMB, when added as early as 4 h after transfection and at 
concentrations as high as 50 nM, did not affect the localization properties of SARS-N 
EGFP.  
 39
Fig. 2.4. Effect of LMB on the localization of SARS-N-EGFP in live cells. (A, B) 
Cells transfected with the control construct, pEGFP-ERev. (C, D) Cells transfected with 
pSARS-N EGFP. (E, F) Cells transfected with the Rev-SARS chimeric construct, 
pRev(NLS-minus)SARS N(368-389). LMB, at a concentration of 10 nM, was added at 
4h after transfection. The results following LMB treatment are shown in the panels on the 
left. Photomicrographs were taken at 18 h after transfection.  
Fig. 2.4. Effect of LMB on the localization of SARS-N-EGFP in live cells. 
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These data further support the notion that the SARS-CoV N protein is not translocated 
into the nucleus. Putative NLS sequences in the N proteins of IBV, TGE and MHV 
coronaviruses are found at amino acids 340-RKRK, 391-PKPQRKR and 360 PKKEKKL, 
respectively ( 11, 24). The corresponding region in SARS-CoV N protein is located in a 
lysine-rich region, between amino acids 369 and 389 (Fig. 2.1). Furthermore, the peptide 
sequence, 369-PKKDKKK of SARS-CoV N, is nearly identical to the well characterized 
NLS in PRRSV N protein (20) as well as a putative NLS in the N protein of IBV (24). To 
determine if the 369-389 peptide possessed nuclear transport activity, we tested the 
ability of the 369-389 peptide to substitute for the NLS of ERev. The pat4 NLS of ERev 
was removed by deleting six amino acids, 159-KRRRKHL, from the C-terminus. The 
construct, pERev(NLS-minus)N(369-389)EGFP, was made by ligating the cDNA 
corresponding to the SARS N 369-389 peptide to the C-terminal end of the mutant ERev 
and followed by EGFP. In Vero cells transfected with pERev(NLS-minus)N(369- 
389)EGFP, the chimeric EGFP protein localized to the cytoplasm (Fig. 2.4E). Blocking 
CRM1 by the addition of 10 nm LMB did not alter the cytoplasmic distribution of the 
chimeric protein (Fig. 2.4F). These data indicate that the 369-389 region of SARS-CoV N 
lacks the ability to substitute for the NLS of a known nucleocytoplasmic protein. 
Presumably, the translocation of TGE, MHV, and IBV coronavirus N proteins across the 
NPC and into the nucleoplasm is dependent on the activities of classical NLS domains 
(11, 24). The presence of eight NLS motifs, scattered between three different regions of 
the SARS-CoV N polypeptide provided a compelling argument for the nuclear and 
nucleolar localization of SARS CoV N. However, the results from this study of N protein 
localization in Vero cells infected with SARS-CoV or transfected with constructs 
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expressing the N gene showed no evidence for the localization of SARS-CoV N to the 
nucleoplasm or nucleolus. The absence of NLS activity within the lysine-rich 369-389 
domain is puzzling. We can propose three mechanisms for the absence of NLS activity 
by the 369-389 peptide. First, even though NLS sequences frequently possess negatively 
charged residues, additional negative charges conferred by acidic amino acid residues or 
phosphorylated serine, threonine or tyrosine residues, can lower the affinity of the 
interaction between the NLS and NLS-binding site on importin-a (12). An aspartic acid 
residue is found at position 371, within the pat7 NLS motif of the SARS CoV-N. 
Additional, negatively charged amino acids are found at positions 378 and 379 (Fig.2.1). 
One more negative charge is made available through the potential phosphorylation of 
threonine at position 377 (1). Therefore, four negatively charged residues may be 
sufficient to neutralize both monopartitie and bipartitie NLS sequences within the 369-
389 region. A second possibility is that the NLS is in a poor conformation to be 
recognized by importin-a. And finally, NLS recognition may be sterically blocked by the 
interaction between the 369-389 region and a cytoplasmic protein. In this study we did 
not evaluate the nuclear localization properties of the NLS motifs located in the other 
regions of the SARS-CoV N protein. Since the SARS-CoV N protein does not appear to 
enter the nucleus, we can assume that these NLS motifs are inactive, inaccessible or there 
are additional domains, which are responsible for retaining N in the cytoplasm.  
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Section 3  
 
 
An aspartic acid residue at position 372 is involved in the cytoplasmic 
retention of the SARS-coronavirus nucleocapsid protein 
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Abstract 
 
 
Previous work characterizing the intracellular localization of the severe acute respiratory 
syndrome coronavirus (SARS-CoV) nucleocapsid (N) protein attributed the absence of 
nuclear localization to the inability of a 369-389 lysine-rich domain to possess a 
functional nuclear localization signal (NLS) sequence (Rowland et al. 2005, J. Virol. 79: 
11507-11512). The capacity of mutated SARS-CoV N 369-389 peptides to restore 
nuclear localization to a NLS-minus equine infectious anemia virus Rev (ERev) protein 
was used to probe the mechanism for the absence of 369-389 NLS activity. Replacement 
of acidic residues with alanines at positions 372, 377 and 379 showed that a single 
alanine for aspartic acid substitution at position 372 restored nuclear translocation 
activity to the ERev-SARS N (369-389) chimeric protein. The replacement of Asp-372 
with alanine in the full-length N protein resulted in the increased accumulation of GFP-
tagged SARS-CoV N protein in the nucleus. A single aspartic acid as a mechanistic basis 
for the absence of NLS function is consistent with structural models of NLS binding to 
importin-α.  A search for other SARS CoV N protein polypeptides with nuclear 
localization activity identified a potential cryptic NLS in the N-terminal region. 
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Introduction 
 
Severe acute respiratory syndrome (SARS) is caused by an enveloped, positive-stranded 
RNA virus, the SARS coronavirus (SARS-CoV).  Along with the arteriviruses, 
toroviruses and roniviruses, the coronaviruses are placed in a single order, Nidovirales (4).  
Even though nidovirus replication is restricted to the cytoplasm, the nucleocapsid protein 
(N) of two arteriviruses, porcine reproductive and respiratory syndrome virus (PRRSV) 
and equine arteritis virus (EAV),  and as representative members of group I, II and III 
coronaviruses localize to the nucleolus during infection. Nuclear accumulation occurs in 
cells transfected with N protein genes fused to the enhanced green fluorescent protein 
(EGFP), demonstrating that the translocation of N across the nuclear pore complex (NPC) 
and accumulation in the nucleolus are independent of other viral proteins (12, 19, 20, 22, 
23, 25, 27,28, 29, 32, 33). Once inside the nucleolus, the N proteins of PRRSV and 
infectious bronchitis virus (IBV) co-localize with major nucleolar proteins (6, 29). 
Presumably, it is the modulation of nucleolar protein function that represents a viral 
strategy that diverts biosynthetic resources from the dividing nucleus to the cytoplasm, 
the site of nidovirus replication (12, 13, 25, 29). 
  
 The classical mechanism for the shuttling of proteins between the cytoplasm and the 
nucleus is mediated by a superfamily of receptor transport proteins known as 
karyopherins. The karyopherins are subdivided into importins, responsible for the 
transport of cargo proteins into the nucleus, and exportins, which shuttle proteins from 
the nucleus back to the cytoplasm.  Linear oligopeptide localization signal sequences are 
 49
responsible for determining the direction of transport.   For instance, translocation of a 
cargo protein from the cytoplasm to the nucleus is initiated through the interaction 
between a nuclear localization signal (NLS) on the cargo protein with the NLS-binding 
site on importin-α (reviewed in 2 and 9). In a similar manner, the transport from the 
nucleus to the cytoplasm involves a nuclear export signal (NES) sequence. Classical NLS 
sequences are composed of short peptide regions enriched in basic amino acid residues. 
Monpartitie NLS sequences contain a single cluster of at least four basic residues and are 
further divided in pat4 and pat7 motifs.  Bipartite NLS sequences contain two basic 
amino acid clusters separated by a 10 amino acid spacer. The NLS binding site of 
importin-α is formed by nine armadillo (Arm) repeats. The formation of a stable complex 
between the peptide NLS and the α-helices of the Arm repeats occurs through a 
combination of hydrophobic and electrostatic interactions.          
 
Based on the predicted peptide sequence of the SARS-CoV N protein gene, Marra et al. 
(20) was the first to identify a unique lysine-rich domain located between amino acids 
369-389 and suggested that the embedded nuclear/nucleolar localization signal sequences 
could play an important role in SARS-CoV cytopathogenesis. The identification of 
topogenic peptide sequence motifs using computer-based programs, such as PSORT 
(Prediction of protein sorting signals and localization sites in amino acid sequences; 
http://psort.hgc.jp/ ) identifies at least eight NLS motifs within the SARS-CoV N protein 
polypeptide, including both monopartite and bipartite NLSs. At least five NLS motifs are 
embedded within the 369-389 region.  Even though bioinformatic analysis predicts its 
nuclear translocation, experimental studies of SARS-CoV N protein localization have 
 50
met with mixed results.  Chang et al. (5) provided the first published report of SARS-
CoV N protein in the nucleus, which was followed by Quinfen et al.(24), who observed 
nuclear accumulation of virus-like particles in infected Vero cells.  In contrast, Timani et 
al. (31), detected only small quantities of N in the nucleus of infected cells and nuclear 
accumulation was absent when recombinant N was expressed in Vero cells as a GFP 
fusion protein.   However, nuclear/nucleolar accumulation of recombinant N-GFP was 
recovered following the removal of amino acids 220 through 231, which covers a 
leucine-rich NES-like motif.  More recently, Jaehwan et al., (2005) did not observe the 
presence of N in the nucleus of infected cells.  However, 10% of cells transfected with a 
plasmid containing N fused to the enhanced cyan fluorescent protein (ECFP) gene did 
show nucleolar accumulation of the tagged protein.  Nucleolar accumulation of N-ECFP 
only became apparent at 72 h after transfection. The removal of the NES-like domain 
failed to increase the percentage of cells with nuclear/nucleolar localization. Surjit et al., 
studying N protein phosphorylation, reported the presence of phosphorylated N in the 
nucleus, suggesting that the intracellular localization of N is determined by the 
phosphorylation state of the N protein (29). We failed to observe N in the nucleus 
following the infection of Vero cells with the SARS-CoV Urbani isolate. Similar results 
were obtained after the transfection of Vero and other cell lines with plasmid constructs 
that expressed N as an EGFP fusion protein. Accumulation of the EGFP tag in the 
nucleus of some cells was attributed to the proteolytic removal of EGFP. The absence of 
N protein nuclear localization was linked to the inability of the 369-389 region to possess 
a functional NLS.  The lack of NLS activity within the 369-389 oligopeptide is intriguing, 
since the 369-PKKDKKK peptide sequence is similar to other well-studied pat7 NLS 
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sequences, including the NLS (126-PKKKRK) of the SV40 large T antigen and the 41-
PGKKNKK peptide sequence in the PRRSV N protein. In addition, the SARS CoV NLS 
369 pat7 motif is nearly identical to the putative NLS, 360-PKKEKKL, reported for the 
IBV N protein (13).  It should be noted that the identification of the IBV N 360-366 
peptide as a functional NLS has yet to be confirmed experimentally.  
 
NLS function is partially dependent on the capacity of key lysine/arginine residues to 
form electrostatic bonds with corresponding negatively charged residues located within 
the NLS binding pocket of importin-a. We hypothesized that negatively charged residues 
located within the 369-389 peptide could interfere with NLS binding. Substituting lysine 
residues at 372, 378 and 379 identified an aspartic acid residue at position 372, which 
when replaced with an uncharged alanine residue was sufficient to restore NLS activity to 
the 369-389 peptide.   Therefore, the presence of an aspartic acid at position 372 plays an 
important role in the retention of the N protein in the cytoplasm. A role for the lysine-rich 
domain in the pathogenesis of SARS-CoV remains to be determined. 
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MATERIALS AND METHODS 
Cells and reagents Vero cells were grown in Eagle minimum essential medium 
supplemented with 10% fetal bovine serum, penicillin-streptomycin and fungizone. Cells 
were maintained at 37oC in 5% CO2. Leptomycin B (LMB) was obtained from Sigma and 
stored at -20 until use. 
Construction of recombinant plasmids The cDNA representing the N gene of the 
Urbani isolate of SARS-CoV was a generous gift of Paul Rota at CDC. PCR was used to 
place EcoRI and BamHI restriction sites on the 5 and 3 ends of the N gene cDNA, 
respectively. The cDNA was cut with the restriction enzymes and cloned into pEGFP-C2.  
The product was a plasmid that expressed the N protein fused to the C-terminus of EGFP. 
Expression of the N-EGFP fusion protein was regulated by the CMV immediate early 
promoter. Truncated N gene cDNAs expressing different regions of the N protein were 
constructed using the same approach. All N gene constructs were confirmed by DNA 
sequencing. The plasmid construct, pEGFP-ERev, which contained the full-length cDNA 
of the EIAV Rev protein (ERev) fused to EGFP, was a kind gift of Susan Carpenter.  The 
NLS of ERev was removed by deleting 24 bases from the 3 end of the full-length ERev 
cDNA, producing the construct, pEGFP-ERev(NLS-).  For transfection, Vero cells were 
plated onto 24-well tissue culture plates. Cells, when 75% confluent, were transfected 
with 2ug of plasmid DNA using lipofectamine 2000 (Invitrogen). Four hours after 
transfection, medium was replaced by maintenance medium and visualized under 
fluorescence microscope (Nikon) 15-18 h later. For LMB treated cells, LMB was added 
at concentrations of 10 nM at between 3-4 h after transfection. 
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Immunostaining and confocal microscopy      Confocal microscopy was performed on 
transfected Vero cells grown on coverslips. Cells were fixed for 10 minutes with 2% 
paraformaldehyde in PBS, washed and counterstained with TO-PRO-3 (Molecular Probes) 
and then viewed on a Zeiss LSM 510 confocal microscope (). For the detection of N 
using an anti-N mAb, cells were fixed in 80% acetone for 10 minutes and then stained 
with SA 46-4 anti SARS N mAb.  The mouse mAb was detected goat anti-mouse IgG 
antibody conjugated to AlexaFluor 594 (Molecular Probes).  All antibodies were diluted 
1:500 in PBS with 5% FBS and incubations performed for 1 h at room temperature 
followed by extensive washing in PBS. Cells were counterstained with TO-PRO-3, 
diluted in blocking buffer, then viewed on a Zeiss LSM 510 confocal microscope.  
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Fig. 3.1.  NLS motifs in SARS-CoV N protein 369-389 peptide.  
(A) Peptide sequence analysis was performed using the Web-based program, PSORT 
(Nakai and Kanehisa, 1992). The  pat4 NLS is defined as a continuous stretch of four 
basic amino acids (lysine or arginine) or three basic amino acids associated with a 
histidine or proline. The pat7 NLS motif starts with a proline and is followed within 
three residues by a segment containing three basic residues out of four. The bipartite 
motif, consists of two basic amino acids, a 10 amino acid spacer, and a five amino acid 
segment containing at least three basic residues.  (B) Wild-type and mutated EGFP-ERev 
PKKDKKKKTDEAQPLPQRQKK
A 
369-PKKDKKKKTDEAQPLPQRQKK-389 
                 KKKK (pat4) 
       PKKDKKKK (pat7) 
                                            PQRQKK (pat7) 
                 KKKKTDEAQPLPQRQKK (bipartite) 
 
C 
   N(369-389)wt   PKKDKKKKTDEAQPLPQRQKK 
   N(369-389)1A  PKKAKKKKTDEAQPLPQRQKK 
   N(369-389)2A  PKKDKKKKTAAAQPLPQRQKK 
   N(369-389)3A  PKKAKKKKTAAAQPLPQRQKK 
  
 KRRKHL 
1                                   159
            GFP                                                    EIAV Rev 
GFP-ERev 
N(369-389)wt 
B 
NLS 
SARS N(369-389) 
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constructs used in this study. (C) Mutant 369-389 peptides containing alanine 
substitutions (identified by underlined residues). 
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RESULTS 
 
Effect of negatively charged amino acid residues on the nuclear localization activity 
of the SARS-N(369-389) peptide.  As shown in Fig. 3.1A, the 369-389 region of SARS 
N possesses multiple NLS motifs, including pat4, pat7 and bipartite signal sequences. In 
a previous study we tested the nuclear transport activity of the SARS-N (369-389) 
peptide using a cis complementation approach to recover nuclear localization of a NLS-
minus equine infectious anemia virus Rev (ERev) protein.  ERev possesses a single 
monopartite NLS, KRRRK, located at the C-terminal end, which is necessary and 
sufficient to import the 165 amino acid ERev protein into the nucleus.  A single, atypical 
NES, 32-PQGPLESDQWCRVLRQSLPEEKIP, is responsible for nuclear export (18, 21). 
Under steady-state conditions, the net activities of the nuclear import and export signal 
sequences favor the accumulation of recombinant EGFP-ERev in the cytoplasm (Fig. 
3.2A). After the addition of the CRM1 exportin inhibitor, LMB, nuclear export is blocked 
and the distribution shifts towards the accumulation of EGFP-ERev in the nucleus 
(Fig.3.2B). To study the nuclear import function of the SARS-N (369-389) peptide, we 
removed the NLS of EGFP-ERev by deleting 24 bases from the 3 end of the ERev full-
length cDNA (see Fig. 3.1B). The truncated construct, pEGFP-Rev (NLS-), when 
transfected into Vero cells expressed a GFP-labeled ERev protein that was retained in the 
cytoplasm, even in the presence of LMB (Fig. 3.2C and D).  The fusion of the SARS-N 
(369-389) peptide to the C-terminus of GFP-ERev(NLS-); see construct N(369-389)wt  
in Fig 3.1B), did not alter the localization properties of the GFP-ERev(NLS-) protein (see 
Fig. 3.2E and F). This result, as reported by us previously, indicates that the 369-389 
peptide lacks a functional NLS (28) 
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Fig.3.2. Localization properties of EGFP-ERev-SARS-N chimeric proteins.  
Photomicrographs of live cells transfected with pEGFP-ERev constructs. Right hand panels 
are cells treated with LMB.   LMB, at a concentration of 10 nM, was added at 4h after 
transfection.  Photomicrographs were taken at 18 h after transfection. 
 
 
One explanation for the lack of NLS activity is the presence of several negatively charged 
amino acid residues, located in and around the NLS motif 369-PKKDKKK. The effect of 
these negative charges would be to either neutralize the positive charges conferred by the 
nearby lysine residues, or to alter the conformation or accessibility of the NLS. Acidic 
residues are found at positions 372, 378 and 379.  An additional source for negative 
charges is found in the post-translational phosphorylation of serine, threonine and 
tyrosine residues by cellular kinases. A single threonine, located at position 377, was 
identified by the computer program, NetPhos (http://www.cbs.dtu.dk/services/NetPhos/; 
3), as a potential target for phosphorylation. We replaced the aspartic and glutamic acids 
within the 369-389 peptide with uncharged alanine residues and tested the ability of the 
mutated peptides to restore nuclear localization to GFP-ERev (NLS-). The peptide 
sequences of wild-type and mutated 369-389 constructs are shown in Fig. 3.1C. The 
replacement of Asp-378 and Glu-379 with alanines, in the construct SARS-N(369-
389)2A, did not alter the localization properties of the EGFP-ERev(NLS-).  Even in the 
presence of LMB, the chimeric protein was retained in the cytoplasm (see Fig. 3.2G and 
H).  The further substitution of Asp-372 with alanine produced the triple mutant, SARS-
N(369-389)3A. In the absence of LMB, the GFP-labeled protein was predominately 
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cytoplasmic (Fig. 2I). However, in the presence of LMB, the GFP-tagged protein 
localized almost entirely to the nucleus (Fig. 3.2J).  Therefore, we prepared a third 
construct, pSARS-N(369-389)1A, which contained a single alanine substitution at 
position 372 (Fig. 3.1C). The localization properties of the SARS-N(369-389)1A protein, 
with and without LMB, were similar to the triple-mutant (Fig. 3.2K and L). These results 
indicate that the replacement of Asp-372 with an alanine is sufficient to restore NLS 
activity to the 369-389 peptide. The replacement of Thr-377 with alanine did not alter the 
localization properties of the ERev(NLS-) protein (data not shown).  
  
Effect of alanine-372 substitution on SARS-CoV N protein localization: In order to 
determine if Asp-372 was important for retaining SARS N in the cytoplasm, we used 
site-directed mutagenesis to replace Asp-372 with alanine within the full length SARS N 
protein.  This was accomplished by replacing the aspartic acid codon sequence, GAC, 
with the alanine codon, GCC. The resulting construct was named pEGFP-SARS-N 
(372A). When screening plasmid constructs for the presence of the Ala-372 mutation, we 
identified a double mutant, which possessed an additional methionine for lysine 
substitution at the adjacent 371 position. This mutation was the result of a change in the 
lysine codon, AAG, to methionine, AUG. This resulting construct was named pEGFP-
SARS-N (371M,372A).  Duplicate wells of Vero cells were transfected with pEGFP-
SARS-N, pEGFP-SARS-N (372A) or pEGFP-SARS-N(371M,372A). At three hr after 
transfection, one well of each construct was treated with LMB and 15 h later the live cells 
were viewed under a fluorescence microscope.  The rationale for the inclusion of LMB 
was based on a report by Timani et al. (31), who identified a leucine-rich NES-like 
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peptide sequence, 220-LALLLLDRLNRL, located in the middle of the SARS-CoV N 
protein. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.3. Localization properties of mutated EGFP-SARS-N proteins.  Right hand  panels 
are the results following treatment of transfected cells with LMB.  Images are of live cells 
except E and F, which are the same cell after fixation prior to imaging. (E) shows EGFP 
green fluorescence and (F) is after staining with anti SARS-Co-N mAb, 46-4 followed by 
AlexaFluor 594 and viewed under a rhodamine filter. Arrows identify the location of the 
nucleus.  
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As reported by us previously, the full-length SARS-N protein when fused to the C-
terminal end of EGFP is retained in the cytoplasm, even in the presence of LMB (see Fig. 
3.3A and B). The localization properties of the EGFP-SARS-N (372A) protein are shown 
in Fig. 3.3C and D.  The EGFP-SARS-N (372A) protein was predominately cytoplasmic, 
with a small number of cells with EGFP in the nucleus. In the presence of LMB, we 
observed a heterogeneous population of fluorescent cells, ranging from cells that retained 
EGFP in the cytoplasm to cells with EGFP exclusively in the nucleus. Examples of the 
various localization patterns in LMB-treated cells are shown in Fig. 3D. One explanation 
for the accumulation of EGFP in the nucleus is the result of proteolytic removal of 
SARS-N (372A) EGFP and the passive diffusion of free EGFP across the NPC and into 
the nucleoplasm. Staining of cells with the anti-N antibody, 46-4, showed that 46-4 
staining co-localized with EGFP in the nucleus of LMB-treated cells (see Fig. 3.3F and 
G). These results indicated that similar to the results for the ERev-SARS-N (368-389) 
chimeric protein, the presence of an alanine at position 372 restored nuclear translocation 
to the SARS-CoV N protein. These results also suggest that SARS-N possesses a NES-
like domain. The localization properties of the SARS-N (371M, 372A) double mutant 
resembled the wild-type N protein (see Fig. 3.3G and H). The absence of nuclear 
accumulation is consistent with the requirement of Lys-371 for NLS function. 
 
 A more quantitative assessment of the effect of LMB on the localization properties of 
wild-type and mutant N proteins is presented in Fig. 3.4.  In this experiment we 
determined the percentage of cells with fluorescence in nuclear and cytoplasmic 
compartments. Data for EGFP-ERev, shown in Fig. 3.4A were included as a positive 
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control. After transfection with pEGFP-ERev, approximately 60% cells contained EGFP-
ERev only in the cytoplasmic compartment. In the presence of LMB the distribution was 
shifted to almost 100% of cells with EGFP-tagged protein in the nucleus. Fig. 3.4B 
shows that approximately 80% of cells expressing EGFP-labeled SARS-N exhibited a 
predominately cytoplasmic distribution, which did not change in cells incubated in the 
presence of LMB. Results for cells transfected with pSARS-N (372A) are shown in Fig. 
3.4 C. In the absence of LMB, EGFP-SARS-N (372A) cells with a predominately 
cytoplasmic distribution were dominant, with only a small shift towards an increased 
percentage of cells with fluorescence in the nucleus (compare open bars in panels B and 
C in Fig. 3.4). In response to LMB, the distribution was further shifted to the right, 
reflecting an increased percentage of cells with fluorescence in the nucleus. However, the 
shift was not as pronounced as the LMB response of EGFP-ERev cells. The results for 
the EGFP-SARS-N (371M, 372A) double mutant were similar to wild-type N (see panel 
D). Collectively, these results indicate that a single aspartic acid residue at position 372 
contributes to the cytoplasmic retention of SARS-CoV N protein.  
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Fig. 3.4. Intracellular distribution of EGFP fluorescence in live cells.  Data for each 
experiment was collected by visually assessing the intracellular distribution of 
fluorescence in Vero cells in at least five microscopic fields.  Results show means and 
standard deviations for data from three independent experiments. Open bars are control 
cells and closed bars after treatment with 10 nM LMB. Vertical axis shows percent cells. 
Key: C>N, fluorescence greater in cytoplasm than nucleus; C=N, fluorescence in 
cytoplasm equal to fluorescence in nucleus; C<N, fluorescence greater in greater in 
nucleus than cytoplasm; N=only, fluorescence on in the nucleus. 
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The N-terminal region in SARS N possesses nuclear localization activity.   In addition 
to the NLS motifs embedded within the 369-389 region, PSORT identified two other 
regions in SARS-N possessing NLS motifs. The first, called NLS-1, contained the pat7 
motif, PKQRRPQ, located between amino acids 38-44. The second NLS motif, called 
NLS-2 possessed overlapping NLS motifs; a pat4 peptide, KKPR, between amino acids 
257 and 260 and a pat7 motif,  259-PRQKRTA. And the third, labeled NLS-3, contained 
the 369-389 peptide. We prepared several N protein gene cDNA constructs containing 
different regions of the N protein fused to EGFP.  The constructs and their nuclear 
localizaton properties are shown in Fig. 3.5A.  Only two constructs, pEGFP-SARS-N(1-
100) and pEGFP-SARS-N(1-200), showed accumulation of the EGFP tag in the nucleus.  
Confocal microscopy of a representative cell transfected with pEGFP-SARS-N(1-100), is 
presented in Fig. 3.5B. The green EGFP-tagged protein accumulated in the same 
compartment as the blue TO-PRP-3 nuclear stain. The only exception was the region 
covered by the nucleolus.  EGFP fluorescence was present in the nucleolus; whereas, TO-
PRO-3 was excluded. The same results were obtained for cells transfected with pEGFP-
SARS-N-1-200. Constructs that contained NLS-1 plus NLS-2, NLS-2 alone, NLS-2 plus 
NLS-3, or NLS-3 alone, remained cytoplasmic. 
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Fig. 3.5. Intracellular localization of EGFP-tagged SARS-CoV N protein fragments. (A) 
SARS-CoV N protein constructs are shown on the left . On the right of each construct 
indicates the presence (+) or absence (-) of localization to the nucleus. Results were 
obtained after visualizing live cells at 18-24 hr following transfection of each plasmid in 
Vero cells.  (B) Confocal microscopy of a representative cell transfected with pEGFP-
SARS-N(1-100). Left image is EGFP fluorescence. The right image shows staining with 
the nuclear stain, TO-PRO-3 , in the same cell. Key: Cy, cytoplasm; Nu, nucleus; No, 
nucleolus. 
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Discussion 
 
The nuclear localization of the nucleocapsid to the nucleus/nucleolus is a common 
property within the nidovirus group. At present, the only exception appears to be the N 
protein of SARS-CoV, which possesses at least eight canonical NLS motifs, and yet is 
retained in the cytoplasm.  In previous work, we attributed the cytoplasmic retention of 
the SARS CoV to the inability of a NLS motif -rich region, between amino acids 369-389, 
to possess nuclear localization activity.  In this study we applied a cis complementation 
approach incorporating a NLS-minus ERev protein to determine the mechanistic bases 
for lack of nuclear localization.  The replacement of a single Asp-372 with alanine was 
sufficient to restore localization activity to the 369-389 peptide.  NLS activity was 
evident by the accumulation of the ERev (NLS-) SARS-N(369-389) chimeric protein in 
the nucleus.  Further support for the importance of Asp-372 was found when Asp-372 
was replaced with Alanine in the native protein. Again the accumulation of EGFP-SARS-
N (372A) protein was evident after the addition of LMB.  However, the effect of LMB 
was not as pronounced compared to ERev.  
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Section IV 
 
 
Conclusion and Future Directions 
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SARS coronavirus is neither believed to be a mutant form not a recombinant of any 
known human coronaviruses. Serological tests have determined Chinese Horse-shoe bats 
to be the original reservoirs and virus has obtained the ability to infect humans. Like 
many othercoronaviruses, SARS-CoV is spread by both fecal and respiratory 
contamination. Development of vaccines and anti-viral therapy for SARS-CoV will 
provide new strategies for other animal and human coronaviruses. 
 
The nucleocapsid protein of the coronaviruses is a highly  immunogenic protein and this 
property is true for SARS-CoV as well. More than 90% of infected patients show 
antibodies against this virus. The N- protein plays a vital role in viral core formation, 
pathogenesis and transcription. These properties make the nucleocapsid an excellent 
target for vaccine development. Antibodies generated against this protein are used for 
diagnostic purposes.  
 
The research documented in this dissertation is an effort to study the role of the N in viral 
pathogenesis of SARS-CoV. Studying the localization pattern of the viral protein upon 
infection is the first step to study its cellular interactions and association with other 
molecules. Although the protein possessed multiple localization signals as predicted by 
PSORT, localization was restricted to the cytoplasm of the (Section 2). Even though the 
various predicted NLSs were similar to the consensus NLS domains, the sequences do 
not serve as active localization domains. The fragment encoding amino acids 369-389 
showed nuclear localization potential. True localization signals possess two very 
important properties. Addition of these signals can localize a non-nuclear protein to the 
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nucleus and a single amino acid mutation in this region results in the loss of nuclear 
targeting property. To test the true localization potential of the 369-389 fragment, we 
attached this fragment to a NLS lacking EIAV-Rev protein. This recombinant protein 
thus was not targeted to the nucleus of the transfected cell (section 2). Thus, the 369-389 
fragment even though capable of localizing to the nucleolus by passive diffusion does not 
participate in active transport and does not target the protein to the nucleus of the cell. 
 
To further understand the potential bipartite signal domain, we analyzed the amino acids 
in this fragment. The results of this study are shown in section 3. This work reflects on 
the role of the aspartic acid at the position 372 on the cytoplasmic retention of the protein. 
Nuclear localization signals are basic amino acids and they interact with the acidic 
aspartic and glutamic amino acids found in the ARM motifs of importin-α. We believe 
that the acidic aspartic residue makes the lysine rich domain incompatible to interact with 
the importin-α interaction regions. To study this possibility, single amino acid mutations 
of the three acidic amino acids were generated.  The mutations at position 378 and 379 
did not alter the localization properties. However, a single point mutation at position 372 
changed the localization of the recombinant protein. Upon addition of LMB, the protein 
retention in the nuclear matrix increased. Additionally, we established the nuclear 
localization ability of SARS-N proteins N-terminal. 
 
The novel localization pattern of the nucleocapsid protein conceivably reflects on unique 
characteristics and mechanisms of this protein. The N protein is the most abundant viral 
protein found in infected cells. Further studies will reflect on the functions and 
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mechanism of action of this molecule and define its role in viral propagation and 
pathogenesis. Fuller understanding of the protein conformation and molecular 
interactions will help in establishing the functional aspect of this protein, and this in turn 
will be instrumental in studying therapeutic targets for virus treatment. 
  
 
